Aslıhan Candevir
- Co-authors
- Behice KurtaranYeşim TaşovaAyşe Seza İnalSüheyla KömürHasan Salih Zeki AksuFiliz KibarFerit KuşçuTülin Gökmen
- Topics
- COVID-19 Clinical Research Studies (5 papers)Hepatitis B Virus Studies (5 papers)Antibiotic Resistance in Bacteria (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaEmerging infectious diseasesVaccines
- Partner nations
- TürkiyeUnited StatesFrance
In The Last Decade
Aslıhan Candevir
49 papers receiving 334 citations
Peers
Comparison fields: 5 of 92
- Epidemiology 133
- Infectious Diseases 102
- Molecular Medicine 58
- Endocrinology 37
- Molecular Biology 36
Countries citing papers authored by Aslıhan Candevir
This map shows the geographic impact of Aslıhan Candevir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aslıhan Candevir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aslıhan Candevir more than expected).
Fields of papers citing papers by Aslıhan Candevir
This network shows the impact of papers produced by Aslıhan Candevir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aslıhan Candevir. The network helps show where Aslıhan Candevir may publish in the future.
Co-authorship network of co-authors of Aslıhan Candevir
This figure shows the co-authorship network connecting the top 25 collaborators of Aslıhan Candevir. A scholar is included among the top collaborators of Aslıhan Candevir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aslıhan Candevir. Aslıhan Candevir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 8 | |
| 7 | 5 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 18 | |
| 11 | 0 | |
| 12 | 7 | |
| 13 | 8 | |
| 14 | 17 | |
| 15 | 13 | |
| 16 | 14 | |
| 17 | 1 | |
| 18 | Stenotrophomonas maltophilia Infections from 2007 to 2011 | 2 |
| 19 | Nosocomial Candida Infections: Microbiological and Clinical Features | 1 |
| 20 | A Retrospective Assessment of Individuals Infected with HIV | 1 |
About Aslıhan Candevir
Aslıhan Candevir is a scholar working on Infectious Diseases, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 57 papers that have together received 360 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Hepatitis B Virus Studies (5 papers) and Antibiotic Resistance in Bacteria (5 papers). The work is most often cited by research in Molecular Medicine (58 citations), Applied Microbiology and Biotechnology (15 citations) and Endocrinology (37 citations). Aslıhan Candevir has collaborated with scholars based in Türkiye, United States and France. Frequent co-authors include Behice Kurtaran, Yeşim Taşova, Ayşe Seza İnal, Süheyla Kömür, Hasan Salih Zeki Aksu, Filiz Kibar, Ferit Kuşçu, Tülin Gökmen, Mustafa Kurthan Mert and Mehmet Satar. Their work appears in journals such as SHILAP Revista de lepidopterología, Emerging infectious diseases and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.